1. Home
  2. VFC vs RGEN Comparison

VFC vs RGEN Comparison

Compare VFC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VFC
  • RGEN
  • Stock Information
  • Founded
  • VFC 1899
  • RGEN 1981
  • Country
  • VFC United States
  • RGEN United States
  • Employees
  • VFC N/A
  • RGEN N/A
  • Industry
  • VFC Apparel
  • RGEN Medical/Dental Instruments
  • Sector
  • VFC Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • VFC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • VFC 7.2B
  • RGEN 7.6B
  • IPO Year
  • VFC N/A
  • RGEN N/A
  • Fundamental
  • Price
  • VFC $18.79
  • RGEN $141.76
  • Analyst Decision
  • VFC Hold
  • RGEN Buy
  • Analyst Count
  • VFC 17
  • RGEN 11
  • Target Price
  • VFC $18.38
  • RGEN $190.25
  • AVG Volume (30 Days)
  • VFC 8.1M
  • RGEN 684.2K
  • Earning Date
  • VFC 10-28-2024
  • RGEN 11-12-2024
  • Dividend Yield
  • VFC 1.92%
  • RGEN N/A
  • EPS Growth
  • VFC N/A
  • RGEN N/A
  • EPS
  • VFC N/A
  • RGEN N/A
  • Revenue
  • VFC $10,093,489,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • VFC N/A
  • RGEN $0.44
  • Revenue Next Year
  • VFC $2.90
  • RGEN $12.13
  • P/E Ratio
  • VFC N/A
  • RGEN N/A
  • Revenue Growth
  • VFC N/A
  • RGEN N/A
  • 52 Week Low
  • VFC $11.00
  • RGEN $113.50
  • 52 Week High
  • VFC $23.09
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • VFC 42.80
  • RGEN 52.33
  • Support Level
  • VFC $19.74
  • RGEN $121.53
  • Resistance Level
  • VFC $20.71
  • RGEN $154.48
  • Average True Range (ATR)
  • VFC 0.77
  • RGEN 7.73
  • MACD
  • VFC -0.28
  • RGEN -0.38
  • Stochastic Oscillator
  • VFC 9.89
  • RGEN 61.41

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Altra, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: